RIPK1 and myeloid sarcoma: TNFα levels are increased in the serum, brain, and cerebrospinal fluid of patients with MS, and RIPK1 is activated in mature oligodendrocytes and neurons in animal models and patients with MS (Picon et al., 2021; Zelic et al., 2021).